curdlan has been researched along with Neoplasms in 9 studies
D-hexose : A hexose that has D-configuration at position 5.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A long-anticipated cancer therapy would deliver the right type of therapeutic agents to the target in control with minimal systemic toxicity." | 1.51 | Preparation and cell activities of lactosylated curdlan-triornithine nanoparticles for enhanced DNA/siRNA delivery in hepatoma cells. ( Baigude, H; Ganbold, T; Han, J; Liu, L; Qi, Y; Wang, X, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yanagihara, S | 1 |
| Kasho, N | 1 |
| Sasaki, K | 1 |
| Shironaka, N | 1 |
| Kitayama, Y | 1 |
| Yuba, E | 1 |
| Harada, A | 1 |
| Bao, Q | 1 |
| Ganbold, T | 3 |
| Bao, M | 2 |
| Xiao, H | 1 |
| Han, S | 2 |
| Baigude, H | 3 |
| Wang, X | 1 |
| Qi, Y | 1 |
| Liu, L | 1 |
| Han, J | 1 |
| Ehexige, E | 1 |
| Xu, J | 1 |
| Zhou, JL | 1 |
| Song, F | 1 |
| Tian, JF | 1 |
| Nie, WC | 1 |
| Wang, XL | 1 |
| Wang, YZ | 1 |
| Yan, JK | 2 |
| Qiu, WY | 1 |
| Wang, YY | 1 |
| Wu, LX | 1 |
| Cheung, PCK | 1 |
| Liang, Y | 1 |
| Zhu, L | 1 |
| Gao, M | 1 |
| Wu, J | 1 |
| Zhan, X | 1 |
| Ma, HL | 1 |
| Chen, X | 1 |
| Pei, JJ | 1 |
| Wang, ZB | 1 |
| Wu, JY | 1 |
| Zhao, Y | 1 |
| Chu, X | 1 |
| Chen, J | 1 |
| Wang, Y | 1 |
| Gao, S | 1 |
| Jiang, Y | 1 |
| Zhu, X | 1 |
| Tan, G | 1 |
| Zhao, W | 1 |
| Yi, H | 1 |
| Xu, H | 1 |
| Ma, X | 1 |
| Lu, Y | 1 |
| Yi, Q | 1 |
| Wang, S | 1 |
9 other studies available for curdlan and Neoplasms
| Article | Year |
|---|---|
pH-Sensitive branched β-glucan-modified liposomes for activation of antigen presenting cells and induction of antitumor immunity.
Topics: Animals; Antigen-Presenting Cells; beta-Glucans; Biocompatible Materials; CD8-Positive T-Lymphocytes | 2021 |
Tumor targeted siRNA delivery by adenosine receptor-specific curdlan nanoparticles.
Topics: Cell Line, Tumor; Humans; Nanoparticles; Neoplasms; Nucleic Acids; Polymers; Receptors, Purinergic P | 2023 |
Preparation and cell activities of lactosylated curdlan-triornithine nanoparticles for enhanced DNA/siRNA delivery in hepatoma cells.
Topics: beta-Glucans; DNA; Drug Carriers; Drug Delivery Systems; Gene Targeting; Gene Transfer Techniques; G | 2019 |
Oxidized curdlan activates dendritic cells and enhances antitumor immunity.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; beta-Glucans; Cell Line, Tumor; Cell Prolife | 2021 |
Electrostatic wrapping of doxorubicin with curdlan to construct an efficient pH-responsive drug delivery system.
Topics: beta-Glucans; Delayed-Action Preparations; Doxorubicin; HeLa Cells; Humans; Hydrogen-Ion Concentrati | 2017 |
Formation and characterization of polyelectrolyte complex synthesized by chitosan and carboxylic curdlan for 5-fluorouracil delivery.
Topics: beta-Glucans; Chitosan; Drug Carriers; Fluorouracil; HeLa Cells; Humans; Nanoparticles; Neoplasms; P | 2018 |
Effective production of biologically active water-soluble β-1,3-glucan by a coupled system of Agrobacterium sp. and Trichoderma harzianum.
Topics: Agrobacterium; Antineoplastic Agents; beta-Glucans; Cell Line, Tumor; Fermentation; Glucose; Humans; | 2018 |
Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin.
Topics: Antineoplastic Agents; beta-Glucans; Cell Line, Tumor; Chitosan; Deoxycholic Acid; Doxorubicin; Drug | 2015 |
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells.
Topics: Animals; beta-Glucans; Cell Differentiation; Chemokines; Cross-Priming; Dendritic Cells; Humans; Imm | 2016 |